Proxy consulting firm Glass Lewis suggests Tesla shareholders reject Musk's compensation plan
因醉鞭名马幌
发表于 2024-5-26 17:08:47
214
0
0
Famous agency consulting firm Glass Lewis announced on May 25th local time that it has urged Tesla shareholders to reject CEO Elon Musk's $56 billion compensation plan, which, if approved, would be the largest compensation plan for a US corporate CEO. The report lists reasons such as excessive scale of compensation agreements, exercise dilution effects, and ownership concentration. It also mentioned that Musk's "series of very time-consuming projects" expanded with his high-profile acquisition of Twitter (now known as X).
In January of this year, the Delaware Court of Equity declared the original compensation plan invalid. Musk subsequently attempted to relocate Tesla's registered address from Delaware to Texas.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Tesla will further consolidate its advantages in the field of autonomous driving - Interview with Tesla Global Vice President Tao Lin
- Will Tesla be kicked out of the 'Tech Seven'? Wall Street is reevaluating Netflix as a backup option!
- Barclays raises Tesla target price from $220 to $235
- Tesla's domestic sales in China exceeded 40000 units in October, a year-on-year increase of 41%
- Tesla's domestic sales in October increased by 41% year-on-year
- Elon Musk responds to Tesla's decision to make phones: they can make them, but they won't unless Apple and Google do something wrong
- Tesla denies appointing its first brand ambassador
- Appointing South Korean Olympic athlete as the first brand ambassador? Tesla denies
- Tesla showcases California charging station plan: 168 parking spaces covered with giant solar panels
- Tesla raises wages of German Gigafactory employees by 4%
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 4 小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 5 小时前
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 7 小时前
- 支持
- 反对
- 回复
- 收藏